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Gas-phase ion/molecule reactions and collision-induced dissociation (CID) were conducted on
[M 1 4H]41 of insulin chain B. This Fourier transform mass spectrometry work involved ions
from the oxidized peptide (with two cysteic acid residues) and its reduced form (with two
cysteine residues). Kinetic behavior during deprotonation and hydrogen/deuterium exchange
reactions indicates that insulin B (ox) ions have two distinct structural types. In contrast,
insulin B (red) ions have only one major reacting population, which has a more compact
structure than the oxidized ions. No significant differences in fragmentation patterns for the
two insulin B (ox) populations were observed when CID was performed as a function of
deprotonating reaction time. However, markedly different fragmentation was found between
[M 1 4H]41 of insulin B (ox) and (red). Therefore, the presence of cysteic acid groups in insulin
B (ox) significantly impacts dissociation and presumably structure. This suggests that some
insulin B (ox) ions are zwitterionic, with the five basic sites protonated and one cysteic acid
group deprotonated. Molecular dynamics calculations revealed several viable structures that
are consistent with the experimental results. For example, the most stable form of the reduced
ion, which is unprotonated at the His10, is very compact and has lost the a-helix of native
insulin. Low energy structures for the oxidized ions include a zwitterion with an intraionic
interaction between anionic Cyx7 and cationic His10, as well as a nonzwitterionic conformer
that lacks a proton at Phe1; both structures retain the a-helix. These structures may account for
the two experimentally observed isomers, although others are possible. In addition, experi-
ments on oxidized insulin B were conducted from methanolic solution, which may denature
the conformation, and pure aqueous solution, which may leave a native conformation. These
differences in solvent composition had no effect on the gas-phase results. (J Am Soc Mass
Spectrom 1999, 10, 928–940) © 1999 American Society for Mass Spectrometry
Electrospray ionization (ESI) mass spectrometryhas afforded scientists a powerful method forstudying the intrinsic properties of biomolecules
in the absence of solvents. The gas-phase conformations
of ESI-generated peptide and protein ions have been an
active area of research in the past few years. Hydrogen/
deuterium (H/D) exchange reactions in solution [1–5]
and in the gas phase [6–13] have been employed to
probe conformations for a variety of systems. Informa-
tion on collision cross sections, which relates to an ion’s
area, has been obtained from measurements of ion drift
times [13–15] and energy losses [16, 17] during flow
through inert gases. Conformational information has
also been obtained from imprints generated by ener-
getic protein ions impacting on surfaces [18].
Proton transfer reactions have yielded evidence for
the existence of stable gas-phase isomers, including
conformational isomers [8, 19–23]. Ogorzalek Loo and
Smith [24] studied proton transfer reactions of protein
ions in a source flow reactor. They found that the
presence or absence of disulfide bonds affected reactiv-
ity; however, changes in solution conditions (which
may yield different conformations) did not affect the
results. More recently, in Fourier transform ion cyclo-
tron resonance (FT-ICR) studies, Williams and co-work-
ers [21] observed dramatically different proton transfer
reactivities for disulfide-intact and -reduced hen egg
white lysozyme ions. In addition, the reactivities of
disulfide-reduced lysozyme [M 1 nH]n1 indicated the
existence of at least two distinct ion structures for n 5
8 –10, 12, and 13.
In our laboratory, reactions of ubiquitin [M 1
nH]n1, n 5 4 – 6, first indicated that proton transfer
could be used to distinguish gas-phase protein and
peptide isomers for isolated charge states [22]. Bimodal
kinetic behavior denoted the presence of multiple ion
structures. Similar behavior was later observed during
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deprotonation reactions and H/D exchange of ubiq-
uitin [M 1 12H]121 [8]. In addition, collision-induced
dissociation (CID), performed as a function of reaction
time with a deprotonating amine, revealed distinct
fragmentation patterns that provided structural infor-
mation on the two populations. These isomeric struc-
tures may be related to differences in conformation
and/or location of added protons.
Several recent studies suggest that zwitterions and
salt bridges can affect the reactivity and structure of
proteins [25–32]. For example, evidence of a gas-phase
salt-bridge structure for singly protonated bradykinin
was found using blackbody infrared radiative dissoci-
ation (BIRD) [28]. The salt bridge involved a deproto-
nated C-terminal carboxylic acid group and one of the
two protonated arginine residues, resulting in a net
singly charged molecular ion. In addition, the presence
of dissociated acidic residues affects low-energy CID of
peptide ions [31, 32]. By neutralizing the charge on
more basic residues, and thus enabling the ionizing
protons to reside on less basic sites along the backbone,
diverse and efficient fragmentation occurs for peptides
containing acidic groups. This neutralization of a highly
basic residue also affects the charge distribution pro-
duced by ESI. Vetter and co-workers [25] investigated
the ESI spectra for pairs of peptides that possess the
same basic structure but are differentiated by the num-
ber of acidic groups (phosphate or sulfonate); the pres-
ence of acidic groups significantly reduced or elimi-
nated the maximum ionic charge.
Gas-phase deprotonation reactions in our laboratory
revealed multiple ion structures for [M 1 nH]n1, n 5
4 and 5, of the peptide bovine insulin chain B [23]. This
30 amino acid peptide, whose sequence is given in
Figure 1, is part of the insulin structure, which contains
chains A and B connected by two disulfide linkages.
Insulin B has five basic residues (i.e., histidine, arginine,
lysine, and the N-terminal residue) that may serve as
protonation sites for ESI. In the oxidized form, there are
two cysteic acid residues with sulfate groups that may
be dissociated, thus providing the opportunity to form
a stable zwitterion structure. The secondary structure of
insulin B, as elucidated by X-ray studies [33–36], is
consistent with solution structures derived from 1H
NMR spectroscopy [37, 38]. The structure includes an
extended conformation over the region residues 1–8
followed by a helical region from residues 9–20. There
is a sharp turn over residues 20–23, with the C-terminal
residues 24–30 in an extended conformation [37]. In
solution, partial unfolding of insulin B may result in
detachment of the carboxylate terminus from the core of
the insulin protein and expose a surface of importance
to receptor binding [38, 39]. In addition, insulin folding
is important because it may affect the pharmaceutical
activity. Ramanathan and Gross [40] have shown that
conformational differences in insulin obtained from
various sources can be detected by solution-phase H/D
exchange (with solutions being analyzed by mass spec-
trometry).
In the present study, the structures of gas-phase
[M 1 4H]41 from insulin B were explored using de-
protonation reactions, gas-phase H/D exchange, and
CID. Additional information was provided by molecu-
lar modeling. This biologically important peptide is an
ideal candidate for such studies because of its relatively
small size (i.e., molecular mass of 3496 Da) and because
deprotonation reactions have previously suggested that
it has multiple ion structures [23]. In addition, the
presence of cysteine residues allows reactivity compar-
isons between the more common oxidized insulin chain
B (with –SO3H) and the reduced form (with –SH).
Throughout this paper these peptides will be referred to
as insulin B (ox) and insulin B (red), respectively.
Although most experiments were performed from a
methanolic solution that might denature conformations,
some experiments were performed using aqueous con-
ditions that may leave the peptide in a more native
conformation. This aqueous solution, which involves
oxidized insulin B, is referred to as insulin B (aq).
Experimental
Mass Spectrometry
All experiments were performed using a Bruker (Bil-
lerica, MA) BioAPEX 47e FT-ICR mass spectrometer.
The instrument is equipped with a 4.7 tesla supercon-
ducting magnet and an external Analytica of Bran-
ford (Branford, CT) ESI source. Details on the use of
this ESI/FT-ICR system have been reported previ-
ously [22].
Oxidized bovine insulin chain B was purchased from
Sigma Chemical (St. Louis, MO) and used without
additional purification. For experiments with a methan-
olic solvent, ions were formed from a solution that
contained insulin B (ox) at 1.1 3 1025 M in 50:50:1
mixture (volume %) of methanol:water:acetic acid. This
solution was introduced into the ESI source at a flow
rate of 45–60 mL/h and electrosprayed across a 4 kV
potential through a heated (200 °C) carbon dioxide
countercurrent of drying gas that was regulated at 16
lb/in.2.
The same ESI conditions were employed for insulin
B (red). This peptide was prepared from intact bovine
insulin, which was also purchased from Sigma. The
disulfide bonds connecting the A and B chains were
cleaved by heating 30 mL of 5.3 3 1025 M insulin with
Figure 1. Amino acid sequence of bovine insulin chain B. Resi-
dues in bold capitals indicate potential protonation sites. Cysteic
acid groups are indicated by “Cyx.”
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70 mL 0.07 M dithiothreitol (DTT) for 10 min [41]. The
resulting solution was diluted to 1 mL in 50:50:1 mix-
ture (volume %) of methanol:water:acetic acid.
For studies with pure aqueous solutions, oxidized
insulin B was present at 1.1 3 1025 M. To augment the
formation of the [M 1 4H]41, this solution was ad-
justed to pH 3.6 with less than 1% (v/v) acetic acid.
Because the ESI conditions outlined above did not
generate ions from this aqueous solution, pneumati-
cally assisted ESI [42, 43] was utilized at a sample flow
rate of 1 mL/h. Carbon dioxide at 20 lb/in.2 was the
pneumatic assist gas (and also the countercurrent gas)
at a regulated pressure of .60 lb/in.2 and a tempera-
ture of 275 °C.
For deprotonation reactions, [M 1 4H]41 were m/z
selected in the FT-ICR cell by correlated frequency
ejection techniques [44] and were allowed to react with
static pressures of reagent gases in the range of (5–30) 3
1028 torr. Bimolecular rate constants were determined
by observing the pseudo first-order change in reactant
intensity as a function of time at a constant pressure.
Pressures were measured with a calibrated ion gauge
[45]. Reported reaction efficiencies (kexp/kcap) are the
ratio of the experimental rate constant (kexp) to the
collision constant that was obtained using the thermal
capture rate constant model (kcap) [46, 47].
Hydrogen/deuterium (H/D) exchange reactions in-
volved m/z-selected [M 1 4H]41 reacting with CD3OD
at static pressures of (7–14) 3 1028 torr. Reaction times
ranged from 0 to 3600 s. Mass spectra were processed
using the maximum entropy method of Zhang et al.
[48], which deconvoluted the peak distribution due to
natural 13C isotopic abundance from the peak distribu-
tion caused by deuterium addition.
Reactions with hydrogen iodide (HI) used an
aqueous solution from Aldrich Chemical (Milwau-
kee, WI) with static pressures of (7–31) 3 1028 torr.
These reactions involved [M 1 4H]41 of insulin B
(ox) and (red), as well as [M 1 10H]101 and [M 1
9H]91 of bovine ubiquitin. In attempts to promote HI
attachment, the experimental sequence involved a
pulsed pressure of .1025 torr for HI, followed by a
pulsed pressure of xenon to ;1024 torr, and a vari-
able reaction delay.
CID experiments utilized sustained off-resonance
irradiation (SORI) [49] to induce fragmentation. Ions
were activated 500–700 Hz off-resonance (either higher
or lower frequency) with a 6.0 Vpp pulse for 50–140 ms
in the presence of a pulsed pressure of argon that
reached a maximum of 1025 torr. The experimental
pulse sequence included: isolation of [M 1 4H]41, a
variable reaction delay (if deprotonation reactions were
used), re-isolation of [M 1 4H]41 to remove unwanted
reaction products, pulsed addition of collision gas,
SORI ion activation, a delay to allow for collisions and
for the argon to pump away, and swept frequency
excitation with image current detection.
Molecular Modeling
Molecular dynamics calculations were performed with
HyperChem for SGI version 4.5 from Hypercube (Wa-
terloo, Ontario, Canada). The starting bovine insulin
crystal structure was downloaded from the Protein
Data Bank [50] and modified in HyperChem to obtain
the insulin B (ox) and (red) structures. Protons were
added or subtracted as necessary to build the various
protonation site isomers for [M 1 4H]41.
Dynamics calculations employed the Bio1 force
field, which is an implementation of the CHARMM
force field [51]. The ions were heated from 0 to 500 K in
1.0 ps, followed by dynamic simulation for 15 ps with
0.001 ps time steps, and then cooling to 300 K in 2 ps.
Geometry optimization was carried out on the final
structures to assure that energy minimized conforma-
tions were obtained. In all cases, calculations were
performed with the entire peptide chain being allowed
to move freely and also with the a-helix (residues 9–19)
[37] frozen during the heating, simulation, and cooling
steps. Reported energy values are the average from ten
or more calculated structures. For nonzwitterion struc-
tures, the reported total Coulomb energy is the sum of
all ten positive–positive charge interactions of [M 1
4H]41 from the oxidized and reduced forms. For zwit-
terions, all 15 positive–positive interactions are
summed and the five positive–negative interactions are
subtracted from this total. Coulomb energy was calcu-
lated using
Coulomb energy 5 f 5 O
ij
zizje
2
4pe0errij
(1)
where rij is the distance between two charged hetero-
atoms in the model structures. Recent experimental [52,
53] and theoretical [54] studies suggest that a value of
1.0 for the dielectric constant er is appropriate for small
multiply charged ions in the gas phase.
Results
Deprotonation Reactions
Deprotonation reactions with a series of reference com-
pounds were performed on [M 1 4H]41, which is the
most abundant charge state produced by ESI on insulin
B. Most work involved insulin B (ox) in a methanolic
solution; however, to determine if solvent was affecting
gas-phase conformation, reactions were performed on
oxidized ions generated in an aqueous solution, insulin
B (aq). Under the solution conditions employed, NMR
studies [37] have found that the peptide retains its
“native” conformation. In addition, the impact of cys-
teic acid versus cysteine groups was investigated by
reactions of insulin B (red) ions.
Figure 2 shows reactant loss curves for the deproto-
nation of [M 1 4H]41 from insulin B (red) and (ox) as a
function of reaction time with 3-fluoropyridine and
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2-fluoropyridine, respectively. Both processes are slow,
with reaction efficiencies on the order of 0.01 to 0.10. As
Figure 2a shows, the data for the reduced ions is linear.
This indicates that the entire ion population deproto-
nates at an equivalent rate. Thus, if isomers are present
in the reduced ions, they cannot be distinguished by
deprotonation. In contrast, for the oxidized ions of
Figure 2b, the markedly nonlinear data is indicative of
at least two (and possibly more) isomeric populations.
By fitting the deprotonation data from insulin B (ox)
to the sum of two exponential functions, experimental
rate constants (kexp) and percentage distributions for the
two ion populations were obtained. These data, which
are summarized in Table 1, indicate that isomers are
only observed when at least one population has suffi-
cient thermal energy to overcome the forward barrier to
deprotonation (reaction efficiency ’ 0.1). For slower
reactions, the magnitudes of the rate constants are too
low to distinguish differences. For faster reactions, the
difference in rate constants becomes negligible (within
experimental error). This is consistent with the previ-
ously reported behavior of isomers from ubiquitin [8,
22], ACTH (11–24), and somatostatin [55].
The chemical nature of the reference compound does
not affect its ability to distinguish between the two
isomers. Isomers were detected by a variety of reference
compounds with gas-phase basicities (GBs) in the range
of 202.9–209.3 kcal/mol. These include an aldehyde, a
substituted pyridine, an amide, a sulfide, and aliphatic
and aromatic amines. Thus, the observed isomers are an
inherent characteristic of the protein and not a function
of its interaction with the neutral compound.
Oxidized insulin ions produced from methanolic and
aqueous solutions have similar reactivities; however,
the aqueous solution was not studied extensively be-
Figure 2. Reactant loss curves for the reaction of insulin B [M 1
4H]41 (a) in the reduced form with 3-fluoropyridine at 6.6 3 1028
torr and (b) in the oxidized form with 2-fluoropyridine at 9.8 3
1028 torr. The logarithm of the abundance of [M 1 4H]41 (relative
to the total abundance for [M 1 nH]n1 product and parent ions)
is plotted as a function of reaction time. For (a), the linear data is
fitted to a single exponential equation, whereas for (b) the curve is
fitted to the sum of two exponentials.
Table 1. Deprotonation results for reactions of [M 1 4H]41 from insulin B
Insulin B
GB
(kcal/mola)
Oxidized Aqueous Reduced
Reference
compound
Reaction
efficiency
%
Isomer
Reaction
efficiency
%
Isomer
Reaction
efficiency
%
Isomer
Pyrrole 201.5 0.00 100 . . .b . . . . . . . . .
Anisaldehyde 202.9 0.01 74 . . . . . . . . . . . .
0.005 26
Aniline 203.2 0.05 100 . . . . . . . . . . . .
2-Fluoropyridine 203.7 0.08 42 0.13 52 0.00 100
0.01 58 0.01 48
N,N-dimethylformamide 204.2 0.15 53 0.22 47 0.00 100
0.02 47 0.03 53
t-Butylsulfide 206.5 0.04 58 0.04 62 0.00 100
0.01 42 0.002 38
m-Toluidine 206.5 0.36 60 0.32 100 . . . . . .
0.10 40
3-Fluoropyridine 207.9 0.10 100 . . . . . . 0.01 100
Allylamine 209.3 0.42 37 0.53 78 0.28 100
0.12 63 0.15 22
3-Bromopyridine 209.9 0.13 100 . . . . . . 0.10 100
Benzylamine 210.2 0.20 100 . . . . . . 0.95 100
aGas-phase basicity values are from [62].
bNo experiment was performed.
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cause it produced considerably lower ion yields. For
both solutions, the fast-reacting population contained
;50%–60% of the ions. The data in Table 1 reveal no
obvious correlation between the GBs of reference com-
pounds and the tendency for either population to be
more prevalent. Also, ESI source voltages had no im-
pact on the isomeric abundances.
For insulin B (red) ions, no evidence of isomers was
found by deprotonation reactions. In addition, the re-
duced ions were less reactive to proton transfer than the
oxidized ions.
Using a reaction efficiency criteria of 0.1 to assign
apparent gas-phase acidities (GAapps) of [M 1 4H]
41 or
apparent gas-phase basicities (GBapps) of [M 1 3H]
31
[23], values obtained are 208.6 6 2.7 kcal/mol for insu-
lin B (red), 206.5 6 2.0 kcal/mol for slow-reacting insu-
lin B (ox), and 204.0 6 2.3 kcal/mol for fast-reacting
insulin B (ox).
Gas-Phase H/D Exchange
For [M 1 4H]41 of insulin B (ox), hydrogen/deuterium
(H/D) exchange reactions yield a bimodal distribution
of product ions that support the existence of two (or
more) isomeric structures. As a function of reaction
time with d4-methanol, Figure 3 shows the maximum
number of exchanges observed for the two populations.
As the data in Table 2 indicate, the fast-reacting popu-
lation contains 40%–50% of the ions and reacts about 5
times faster than the slow-reacting population. Of the 58
labile hydrogens available for exchange, a maximum of
54 exchanges were observed after 60 min with a d4-
methanol pressure of 7.3 3 1027 torr. At these longer
reaction times, the isomeric envelopes had merged and
differences in the number of exchanges between the
isomers could not be ascertained.
Because of the low [M 1 4H]41 intensities produced
by insulin B (aq), H/D exchange was only conducted
with this system at relatively short reaction times (i.e.,
,60 s). However, two envelopes of exchanged peaks
were again observed. There was no obvious difference
in reactivity between ions formed from the aqueous and
methanolic solutions.
In H/D exchange studies for insulin B (red) ions, a
single peak distribution is observed. Figure 4 compares
typical H/D exchange spectra of oxidized and reduced
ions. There is a clear distinction in their reactivity with
d4-methanol, even though the only primary structure
difference is the cysteic acid versus cysteine groups. The
exchange rate constant for the insulin B (red) ions (from
Table 2) correlates well with that of the fast-reacting
population of insulin B (ox). However, insulin B (red)
only exchanged a maximum of 24 hydrogens, whereas
the oxidized form underwent 54 exchanges. This im-
plies that the two peptides have completely different
conformations.
To insure that differences in H/D exchange were
unrelated to conformational differences induced by the
solvent systems, experiments were performed on insu-
lin B (ox) in the presence of dithiothreitol. That is,
insulin B (ox) and insulin (red) were studied using the
same solution compositions. The presence of dithiothre-
itol did not affect the insulin B (ox) reactions: two
envelopes of peaks consistent with the presence of two
isomers remained.
Hydrogen Iodide Reactions
In studies employing a quadrupole ion trap (QIT) mass
spectrometer, Stephenson and McLuckey [56, 57] found
that hydrogen iodide (HI) molecules may attach to a
peptide ion, producing [M 1 nH 1 xHI]n1, where x 5
the number of unprotonated basic sites on the ion. This
reaction appeared ideal for providing information on
protonation sites for insulin B (ox) [M 1 4H]41 because
zwitterionic and nonzwitterionic structures would un-
dergo differing numbers of attachments. Unfortunately,
in our FT-ICR studies, this reaction did not occur with
either insulin B (ox) or (red) ions. In addition, we did
not observe this reaction for ubiquitin ions, which
Stephenson and McLuckey found to readily react in
their study [57]. Attempts to mimic .1025 torr range
QIT pressures by pulsed valve addition of inert gas in
Figure 3. Plot of the maximum number of H/D exchanges vs.
reaction time for the two reacting populations for insulin B [M 1
4H]41 with CD3OD at 1.3 3 10
27 torr. The bold line indicates the
faster-reacting population; the dashed line indicates the slower-
reacting population.
Table 2. Hydrogen/deuterium exchange results for reactions
of [M 1 4H]41 from insulin B
Insulin B
form kH/D
a
%
Isomer
Maximum
exchanges
Oxidized 1.3 (60.2) 3 10212 b 40–50 54c
2.7 (60.7) 3 10213 50–60 .49d
Reduced 1.8 (60.3) 3 10212 100 24
aUnits of cm3 molecule21 s21.
bMean (6 standard deviation) for multiple data sets.
c[M 1 4H]41 has 58 labile hydrogens.
dAt longer reaction times, the slow- and fast-reacting modes merged
into one extended distribution. Thus, the maximum exchanges for
slow-reacting ions could not be determined.
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the FT-ICR still did not induce a reaction. The reason
why HI will attach under QIT conditions, but not those
of our FT-ICR, is unknown.
CID
In previous studies on ubiquitin [M 1 12H]121, SORI-
CID revealed that the two isomers had somewhat
different dissociation patterns [8]. Figure 5a shows the
SORI-CID spectrum of [M 1 4H]41 from insulin B (ox);
under these conditions, both isomers are present. When
a reaction delay is added to the sequence, the fast-
reacting isomer can be selectively depleted by reaction
with 2-fluoropyridine or t-butylsulfide until it accounts
for less than 5% of the [M 1 4H]41. The SORI-CID
spectrum for the remaining slow-reacting isomer (data
not shown) is virtually identical to the spectrum of
Figure 5a. Thus, the isomers cannot be elucidated by
CID. Also, no significant difference was found between
the SORI-CID spectra of insulin B ions produced from
methanolic and aqueous solutions.
For [M 1 4H]41 of insulin B (ox), the major CID
fragments were b and y ions. Although it is possible for
proton movement during ion activation, especially in
cases of high Coulomb repulsion [58, 59], in general
these dissociation patterns may provide information on
protonated sites in the peptide. ESI primarily proton-
ates the more basic amino acid residues [60, 61], which
are Phe1, His5, His10, Arg22, and Lys29 for insulin B. The
sequence of Figure 1 shows that residues 1–16 contain
three basic sites, but only two sites are protonated in the
smallest b-ions fragments, b15
21 and b16
21. For larger
N-terminal fragments, the increased charge state to
form bn
31, n 5 24 –26, suggests that Arg22 is proton-
ated. The single charge on C-terminal fragments y3
11,
y4
11, and y6
11 support protonation of Lys29. Therefore,
the data suggests the possibility that varying protona-
tion at Phe1, His5, His10, and Cyx7 may play a role in the
gas-phase isomers observed for [M 1 4H]41 from insu-
lin B (ox).
Figure 5b shows the SORI-CID spectrum of [M 1
4H]41 from insulin B (red). The spectrum contains
predominantly b and y fragments. Although the highest
charge state found for the fragments is 31, the spec-
trum consists mainly of 21 and 11 ions. The smallest b
ion, b10
21, suggests protonation at two of the three
available protonation sites (Phe1, His5, His10) for the
first ten residues. The C-terminal ions, y3
11 and y4
11,
support protonation at Lys29. Because arginine is by far
the most basic amino acid [62], it is reasonable to
assume that Arg22 is also a protonation site.
There is a clear distinction in fragmentation patterns
between ions from insulin B (ox) and (red). For the
oxidized form, Figure 5a shows a number of fragments
with a maximum charge state of 31. Also, b ions
dominate over y ions. In contrast, the reduced form of
Figure 5b has more prevalent y ions, but still a signifi-
cant number of b ions. Thus, the presence of the cysteic
acid groups in insulin B (ox) affects the fragmentation
patterns. This phenomenon is not unprecedented.
Figure 4. H/D exchange spectra of [M 1 4H]41 for (a) insulin B (ox) and (b) insulin B (red) with
CD3OD at 1.3 3 10
27 torr after 120 s. The experiments were performed on the same day employing
the same experimental conditions.
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Gaskell and co-workers [31, 63] have reported that
intraionic interactions between cysteic acid groups and
basic residues significantly affect CID spectra.
Beauchamp and co-workers [30] have observed a simi-
lar effect for other peptide ions that may have acid–base
zwitterionic interactions.
Molecular Dynamics Calculations
Molecular modeling was performed on the protonation
site isomers for insulin B [M 1 4H]41. For nonzwitter-
ion structures, each isomer has one of the five basic sites
unprotonated. The calculations included both oxidized
cysteic acid (–SO3H) and reduced cysteine (–SH) forms.
To probe the possibility of zwitterionic conformers for
insulin B (ox), calculations were also carried out on
structures with an anionic cysteic acid group (–SO3
2)
and the five basic sites fully protonated. Figure 6
displays the starting ribbon structure for insulin B (ox)
[M 1 4H]41 that was obtained by modifying a structure
of insulin from the Protein Data Bank [50]. In all cases,
calculations were performed with the a-helix (residues
9–19) [37, 64] both frozen (intact) and allowed to move
randomly.
For each protonation site isomer, several conformers
were found with similar energies and overall geome-
tries but with differences in bond length and angles.
Table 3 gives average electrostatic and potential ener-
gies obtained for the various structures. The data reveal
a clear difference in the potential energy of structures
with the a-helix frozen versus random movement. The
Coulomb energies are not as distinct. Because Coulomb
energies are calculated using distances between
charges, a higher Coulomb energy usually means a
more compact structure.
It is important to note that many structures of similar
energies were found, and there are likely to be other
Figure 5. SORI-CID mass spectra obtained from [M 1 4H]41 generated from a methanolic solution
of (a) insulin B (ox) and (b) insulin B (red).
Figure 6. The starting structure downloaded from the Protein
Data Bank and modified to oxidized bovine insulin chain B.
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low energy structures that our calculations did not
reveal. The discussion below highlights some general
trends that are observed. However, other interpreta-
tions may also be consistent with the experimental data.
The two lowest energy nonzwitterion structures for
insulin B (ox) have the helix frozen and are unproto-
nated at His10 or Phe1. The potential energies are similar
(265 6 13 and 264 6 14 kcal/mol, respectively) but
their Coulomb energies vary greatly (204 6 32 versus
151 6 39 kcal/mol). Figures 7 and 8 give typical struc-
tures for these ions. Structures lacking a proton at His10,
such as Figure 7, are clearly more compact. Here, the
C-terminal region after the a-helix (residues 21–30) is
folded back onto the peptide core with the protonation
sites Arg22 and Lys29 being further stabilized by in-
tramolecular hydrogen bonding (H bonding). For Fig-
ure 8 with Phe1 unprotonated, these regions have
moved away from the core with a reduction in the
number of H-bonding interactions. The result is a more
elongated conformation.
As the data in Table 3 indicate, zwitterionic struc-
tures for the oxidized ions are lower in energy than
nonzwitterionic forms. Structures with an anionic cys-
teic group at Cys19 and the helix allowed to change
randomly give the lowest potential energies (2171 6
13 kcal/mol). However, removal of helical restriction
leads to a more compact structure, with more H bond-
ing and higher Coulomb repulsion. Typical structures,
as shown in Figure 9, are relatively compact and retain
Table 3. Molecular modeling results for [M 1 4H]41 from insulin B
Insulin B
form
Unprotonated
residuea
Helix
conformationb
Potential energy
(kcal/mol)
Total Coulomb
energy
(kcal/mol)
Oxidizedc Phe1 frozen 264 6 14 151 6 39
Phe1 random 0 6 9 164 6 21
His5 frozen 236 6 18 153 6 17
His5 random 239 6 12 193 6 19
His10 frozen 265 6 13 204 6 32
His10 random 218 6 11 191 6 22
Arg22 frozen 29 6 15 174 6 19
Arg22 random 217 6 15 181 6 23
Lys29 frozen 232 6 12 194 6 36
Lys29 random 225 6 15 193 6 31
Zwitteriond Cys7 frozen 294 6 22 89 6 29
Cys7 random 2156 6 24 214 6 54
Cys19 frozen 266 6 20 120 6 30
Cys19 random 2171 6 13 176 6 47
Reducede Phe1 frozen 258 6 20 141 6 27
Phe1 random 2145 6 29 142 6 32
His5 frozen 284 6 10 161 6 16
His5 random 2146 6 19 197 6 20
His10 frozen 284 6 20 163 6 18
His10 random 2165 6 14 226 6 17
Arg22 frozen 243 6 15 177 6 37
Arg22 random 2101 6 27 169 6 25
Lys29 frozen 227 6 19 210 6 21
Lys29 random 298 6 24 173 6 18
aUnprotonated basic residues (Phe1, His5, His10, Arg22, Lys29) are neutral, whereas unprotonated Cys7 and Cys19 are anionic (SO3
2).
bThe a-helix, residues 9–19, are not permitted to change (frozen) or allowed to move freely (random) during the heating, simulation, and cooling
steps.
cCysteine residues are oxidized, fully protonated, and neutral (–SO3H).
dCysteine residues are oxidized but one residue is anionic (–SO3
2). All five basic residues are protonated.
eCysteine residues are reduced (–SH).
Figure 7. Typical low energy structure of insulin B (ox) [M 1
4H]41 for His10 unprotonated. The a-helix was frozen during the
calculations. Asterisks indicate protonation sites.
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none of the secondary structural features of the starting
structure (Figure 6). A zwitterionic interaction occurs
between Arg22 and Cys19 with a distance of 2.2 Å
between a proton on the guanidyl nitrogen and the
dissociated oxygen in the anionic sulfate group.
Figure 10 displays a low energy structure for anionic
Cys7 with the a-helix frozen. The potential energy for
this isomer is moderately low (294 6 22 kcal/mol) but,
perhaps more significant, the calculated Coulomb en-
ergy (89 6 24 kcal/mol) is over 30 kcal/mol lower than
that of any other isomer. This is because the structure is
very elongated with the region of residues 21–30 fold-
ing away from the helix. A zwitterionic interaction is
observed between His10 and Cys7 with a distance of 2.1
Å between the proton and the anionic oxygen.
Structures with reduced cysteine residues possess
lower overall potential energies than their correspond-
ing oxidized forms. In addition, the lowest energy
reduced structures are generally more compact. How-
ever, in contrast to the insulin B (ox) results, reduced
structures are lower in potential energy when the
a-helix is destroyed during the dynamics calculations.
In agreement with the insulin B (ox) results, the Cou-
lomb energy is usually lower when the helix is retained.
The insulin B (red) structure with an unprotonated
His10 has the lowest potential energy (2165 6 14 kcal/
mol), but the highest Coulomb energy (226 6 17 kcal/
mol), of all of the isomers under study. This compact
structure, shown in Figure 11, has an unusually high
Coulomb energy because of the very short distance (i.e.,
6 6 2 Å) between Arg22 and Lys29. Moreover, two other
isomers, unprotonated Phe1 and His5, also have rela-
tively low potential energies (2145 6 29 and 2146 6
19 kcal/mol, respectively). Their conformations are
more elongated and have considerably lower calculated
Coulomb energies (142 6 32 and 197 6 20 kcal/mol,
respectively). Thus, it is difficult to make conclusions
about which structure is more favored during ion
formation by ESI.
Discussion
Methanolic Versus Pure Aqueous Solutions
No difference was found in reactivity or CID between
[M 1 4H]41 produced by oxidized insulin B in meth-
Figure 8. Typical low energy structure of insulin B (ox) [M 1
4H]41 for Phe1 unprotonated. The a-helix was frozen during the
calculations. Asterisks indicate protonation sites.
Figure 9. Typical low energy structure for insulin B (ox) [M 1
4H]41 with all basic sites protonated and Cyx19 unprotonated. The
a-helix was free to move during the calculations. Asterisks indi-
cate protonation sites.
Figure 10. Typical low energy structure for insulin B (ox) [M 1
4H]41 with all basic sites protonated and Cyx7 unprotonated. The
a-helix was frozen during the calculations. Asterisks indicate
protonation sites.
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anolic and pure aqueous solutions. In addition, the two
solutions yielded similar ionic charge distributions by
ESI. The pH of the aqueous solution was chosen be-
cause solution-phase insulin retains its native confor-
mation under these conditions [37]. Thus, one explana-
tion for our data is that both solutions produce gas-
phase ions with near native conformations. Another
possibility is that the ESI process induces a distribution
of ionic conformers that is independent of the solvent
system. The effects of solvent on ESI ion populations are
not well established. Several peptide studies [3, 65, 66]
have noted that aqueous solutions produce lower
charge states than methanolic solutions. Lower charge
states have been interpreted as involving more folded,
native ions. However, our observation that the solvent
does not affect gas-phase reactivity is not without
precedent. For several common proteins, Ogorzalek
Loo and Smith [24] found no significant deprotonation
reactivity differences between ions produced from var-
ious solvent compositions.
Protonation Sites
Insulin B has five sites that might be protonated for
[M 1 4H]41: Phe1, His5, His10, Arg22, and Lys29. When
considering nonzwitterion structures, the CID results
and the potential energies obtained from molecular
modeling suggest that the unprotonated site is either
Phe1, His5, or His10. Intrinsic basicity considerations [62]
alone would also support the lack of protonation on the
less basic Phe1. In addition, it should be noted that, as
the structures of Figures 7 and 8 illustrate, changes in
protonation site can greatly change conformation.
Previous ESI studies in our laboratory [23] revealed
that insulin B (ox) produces a maximum charge state of
51, corresponding to protonation at the five basic sites.
Some evidence was noted for bimodal deprotonation
reactivity; however, the low ion intensity for [M 1
5H]51 made it difficult to conclusively prove the exis-
tence of isomers. Deprotonation reactions with 131, the
maximum charge state for ubiquitin [8] did not reveal
gas-phase isomers, although isomers were observed for
121. It was proposed that these differences may indi-
cate protonation site isomers, which are possible for
121 but not 131. In addition to affecting conformation,
differences in protonation sites may be the result of
conformation differences in the native solution-phase
protein, which would affect the accessibility of sites to
protonation.
Structures of [M 1 4H]41 from Reduced Insulin B
Deprotonation and H/D exchange reactions both re-
vealed only a single population of [M 1 4H]41 from
insulin B (red). Because this is a simpler system than the
oxidized ions, it will be considered first.
H/D exchange has been demonstrated as an effec-
tive probe for conformational isomers [6, 8, 12, 13]. For
insulin B (red), the presence of only a single distribution
of exchanged ions suggests that there is one predomi-
nant type of conformation or conformations with simi-
lar reactivity. The reduced ions undergo far fewer
exchanges than the oxidized ions. The established in-
terpretation of gas-phase H/D exchange results [6, 12]
is that compact conformations exchange to a lesser
extent than diffuse conformations. A recent report in
our laboratory suggests that this interpretation is not
always applicable [11]. Low levels of exchange may also
occur for elongated structures where labile hydrogens
are too far away from the peptide backbone to stabilize
a H-bonded intermediate. However, our calculated
structures suggest that this is not occurring in insulin B
ions. For even the most elongated structures, all proto-
nation sites should be close enough to the peptide
backbone to form a H-bonded intermediate.
Using the interpretation that more compact struc-
tures H/D exchange less, [M 1 4H]41 of insulin B (red)
are more compact than [M 1 4H]41 from insulin B (ox).
As shown in Figure 11, the lowest energy structure
obtained by molecular modeling on the reduced ions is
very compact. Of the 58 labile hydrogens, only approx-
imately 20 are readily accessible to the deuterating
reagent; the remainder are buried by the peptide chain
and may be very slow to exchange. (The approximate
number of accessible hydrogens was determined by
manual manipulation, in the HyperChem program, of a
CD3OD structure interacting with the modeled peptide
ion structures.) This is consistent with the experimental
observation of only 24 exchanges for the reduced ions.
In addition, it is important to note that, whereas the
structure of Figure 11 is consistent with the experimen-
tal data, other low energy, compact structures with
varying sites of protonation also exist for insulin B (red)
ions.
Figure 11. Typical low energy structure for insulin B (red) [M 1
4H]41 with His10 unprotonated. The a-helix was free to move
during the calculations. Asterisks indicate protonation sites.
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Structures of [M 1 4H]41 of Oxidized Insulin B
Deprotonation reactions and H/D exchange both re-
vealed two populations of [M 1 4H]41 from insulin B
(ox). Experiments involving CID as a function of de-
protonation time did not show any distinct differences
in dissociation patterns between the two isomers. How-
ever, dramatically different fragmentation exists be-
tween oxidized and reduced insulin B ions. Gaskell and
co-workers have reported a similar effect for a variety of
peptides containing cysteine and cysteic acid residues
[31, 32, 63]. This indicates that the cysteic acid group is
very important to the structure of the oxidized ions and
supports the existence of zwitterion structures having
positive/negative intraionic interactions.
The charge state distribution of ions generated by
ESI also suggests that zwitterion structures are impor-
tant. In the spectrum of insulin B (red), we observe a
significant increase (;500%) in abundance of [M 1
5H]51, when compared to the spectrum of insulin B
(ox); under similar conditions insulin B (ox) does not
yield [M 1 5H]51. A similar effect has been reported by
Svoboda et al. [25]. They studied ESI ion formation for
several peptides, including insulin B (ox) and (red).
Their results showed that acidic groups effectively
eliminate the maximum charge state [M 1 5H]51 ob-
served for insulin B (ox), thus enhancing the formation
of [M 1 4H]41. Svoboda et al. [25] suggested that at
least one of the cysteic acid groups was dissociated (i.e.,
anionic) and this “neutralized” a protonated residue.
In our experiments, both slow- and fast-reacting ions
from insulin B (ox) exchanged the vast majority of their
labile hydrogens. This suggests that both isomers have
open conformations, although the slow-reacting ions
may be somewhat more compact. The molecular mod-
eling calculations revealed at least two low energy
structures that are diffuse.
One elongated structure is that of Figure 10, with all
five basic sites protonated and Cyx7 unprotonated. The
unprotonated Cyx7 intereacts with protonated His10 in
the final structure to form a stabilizing zwitterionic
interaction. For these typical calculated structures, only
;9 of the 58 labile hydrogens are buried and may be
inaccessible to H/D exchange. This is in good agree-
ment with the experimental data showing that the
faster-reacting population of [M 1 4H]41 from insulin
B (ox) exchanged all but four of their labile hydrogens.
In considering how this structure might undergo pro-
ton transfer, all five basic sites are in orientations that
should be accessible to deprotonating neutrals, which
may enhance the rate of deprotonation. Proton transfer
may also be enhanced by the relatively low basicity of
this structure’s least basic protonation site, Phe1. For
example, the GB of the amino acid phenylalanine is
212.5 kcal/mol, whereas the GB of histidine is 227.1
kcal/mol [62]. The retention of the a-helix is another
attractive feature of this structure. In mass-analyzed ion
kinetic energy studies of the peptide melittin, Kaltashov
and Fenselau [67] found that the a-helix is retained in
the gas phase.
Another elongated low-energy conformer is shown
in Figure 8, for a nonzwitterionic system which Phe1 is
unprotonated. This structure also has the advantage of
retaining the a-helix. Typical conformers for this spe-
cies have ;11 of their labile hydrogens buried, which is
consistent with the experimental observation that the
slow-reacting insulin B (ox) isomer has about nine
unexchanged hydrogens. In this structure, the protona-
tion sites of His5 and His10 are generally accessible and
may be readily deprotonated.
The two elongated structures noted above are lack-
ing protons at Cyx7 and Phe1, respectively. If these two
structures (or similar structures) account for the two
dominant populations of oxidized ions, this would
explain why CID experiments as a function of deproto-
nation time did not show distinct differences in disso-
ciation patterns between the two isomers. The smallest
b fragment observed is b15
21. This encompasses three
sites that may be protonated (Phe1, His5, and His10) and
one site that may be deprotonated (Cyx7). Therefore,
any variations among the isomers in protonation/de-
protonation at these sites would probably not be re-
flected in the CID spectra.
There is currently no way to make a definitive
statement about the structures of the two isomeric
populations from [M 1 4H]41 of insulin B (ox). In
addition, the fact that gas-phase ion chemistry reveals
two reacting populations only means that a minimum of
two predominant structures exist. The isomers dis-
cussed above, with zwitterionic Cyx7 unprotonated and
nonzwitterionic Phe1 unprotonated, are the two mod-
eled structures that best explain the experimental data.
It is possible that they account for the two ion popula-
tions found by gas-phase ion/molecule reactions. How-
ever, it is important to note that there are other possi-
bilities. For example, a nonhelical system with Cyx19
unprotonated gave the lowest calculated potential en-
ergy (Figure 9). However, the compactness of this
structure is not consistent with the experimental H/D
exchange data, which shows around 50 exchanges. For
models of this isomer, roughly 25 of the labile hydro-
gens are buried and are unlikely to H/D exchange; this
means that only 33 exchanges might occur.
Conclusion
Evidence for the presence of two isomers for [M 1
4H]41 insulin B (ox) was obtained by deprotonation
reactions and H/D exchange. No significant difference
in reactivity was found for insulin B (ox) generated
from a methanolic solution and an aqueous solution.
Isomers were observed under both solution conditions.
For ions from insulin B (red), only one major reacting
population was found by deprotonation and H/D ex-
change. The CID fragmentation patterns for reduced
and oxidized ions were dramatically different. This
suggests that the presence of cysteic acid residues of
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insulin B (ox) has a dramatic impact on the peptide’s
conformation, which supports the presence of acid–
base zwitterionic interactions in insulin B (ox) ions.
The H/D exchange reactions suggest that the two
insulin B (ox) structures are more open than the insulin
B (red) structure. Molecular dynamic simulations re-
vealed several viable low energy conformations. For the
two isomeric structures of [M 1 4H]41 from insulin B
(ox), at least one zwitterion structure is proposed with
an intraionic interaction between an anionic cysteic acid
group and a protonated group. Differences in protona-
tion site and the presence or absence of insulin’s a-helix
may also impact the gas-phase structures.
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